Cannabis Science and Technology is pleased to announce the addition of Allegra Leghissa, PhD, to its editorial advisory board (EAB).
Allegra Leghissa, PhD
Cannabis Science and Technology is pleased to announce the addition of Allegra Leghissa, PhD, to its editorial advisory board (EAB).
Dr. Allegra Leghissa graduated from the University of Bologna, Italy with an undergraduate degree in Chemistry in 2014 and a PhD in analytical chemistry from the University of Texas, Arlington in 2018. Under the supervision of Professor Kevin Schug, she worked on the analysis of terpenes and cannabinoids in cannabis and specifically delta-9-THC metabolites by gas chromatography–tandem mass spectrometry (GC–MS/MS). She also had some experience with the analysis of these components by liquid chromatography (LC)–MS/MS. Her experience in the field of cannabis testing was solidified through participation in relevant conferences and seminars.
Dr. Leghissa is currently an LC–MS/MS application engineer with Shimadzu France.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.